Fukuoka Y, Hugli T E
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA 92037.
J Immunol. 1990 Sep 15;145(6):1851-8.
Incubation of radiolabeled human C3a with rat peritoneal mast cells resulted in high levels of uptake and extensive degradation of the ligand. Both cell-bound and free radiolabeled human C3a underwent extensive degradation by rat mast cells even at 0 degrees C. We examined several protease inhibitors for their ability to prevent degradation of radiolabeled human C3a by the rat mast cells. The inhibitors PMSF, chymostatin, and soybean trypsin inhibitor were most effective in preventing radiolabeled human C3a degradation. Degradation of the cell-bound ligand was totally inhibited only by PMSF. These compounds are effective inhibitors of a chymotrypsin-like enzyme (chymase) extracted from rat mast cells. Chemical cross-linking of radiolabeled human C3a to surface components on the rat mast cells, in the presence of PMSF, revealed one major and two minor bands. The mast cell component in both the major and minor bands proved to be chymase-associated based on a direct comparison with purified chymase isolated from rat mast cells. However, neither antichymase antibody nor chymase inhibitors influenced the degranulating activity of C3a on rat mast cells that occur independently of the C3a-chymase interactions. We conclude that there are neither specific C3a-binding sites on rat mast cells nor specific receptors whose occupancy leads to cellular activation. Although human C3ades Arg is inactive on guinea pig ileal and lung tissue, it binds to and induces degranulation of rat mast cells, as well as enhances vascular permeability in rat skin, at concentrations nearly identical to that of intact C3a. The fact that both C3a and C3ades Arg stimulated mast cell activation, at concentrations in excess of 10(-6) M, argues against specific binding sites for the anaphylatoxin on rat mast cells. It is proposed that the cationic C3a molecule activates rat mast cells in a secretory and nonlytic manner by a nonspecific mechanism similar to that of other polybasic compounds.
用放射性标记的人C3a与大鼠腹膜肥大细胞一起温育,导致该配体的高水平摄取和广泛降解。即使在0℃,细胞结合的和游离的放射性标记人C3a均被大鼠肥大细胞广泛降解。我们检测了几种蛋白酶抑制剂阻止大鼠肥大细胞降解放射性标记人C3a的能力。抑制剂苯甲基磺酰氟(PMSF)、抑糜酶素和大豆胰蛋白酶抑制剂在阻止放射性标记人C3a降解方面最有效。仅PMSF能完全抑制细胞结合配体的降解。这些化合物是从大鼠肥大细胞中提取的类胰凝乳蛋白酶(糜酶)的有效抑制剂。在PMSF存在下,将放射性标记人C3a化学交联到大鼠肥大细胞的表面成分上,显示出一条主要条带和两条次要条带。基于与从大鼠肥大细胞中分离的纯化糜酶的直接比较,主要和次要条带中的肥大细胞成分均被证明与糜酶相关。然而,抗糜酶抗体和糜酶抑制剂均不影响C3a对大鼠肥大细胞的脱颗粒活性,这种活性独立于C3a-糜酶相互作用而发生。我们得出结论,大鼠肥大细胞上既没有特异性C3a结合位点,也没有因占据而导致细胞活化的特异性受体。尽管人C3a去精氨酸(C3ades Arg)对豚鼠回肠和肺组织无活性,但它能结合并诱导大鼠肥大细胞脱颗粒,并且在与完整C3a几乎相同的浓度下增强大鼠皮肤的血管通透性。C3a和C3ades Arg在浓度超过10^(-6) M时均刺激肥大细胞活化,这一事实反对大鼠肥大细胞上存在过敏毒素的特异性结合位点。有人提出,阳离子C3a分子通过一种类似于其他多碱性化合物的非特异性机制以分泌性和非溶解性方式激活大鼠肥大细胞。